DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
47 hedge funds and large institutions have $9.77M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
47
Holding in Top 10
1
Calls
$1.29M
Puts
–
Top Buyers
| 1 | +$220K | |
| 2 | +$207K | |
| 3 | +$150K | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$96.3K |
| 5 |
TPMI
Tilden Park Management I
New York
|
+$12K |
Top Sellers
| 1 | -$4.46M | |
| 2 | -$1.34M | |
| 3 | -$1.18M | |
| 4 |
Tiger Global Management
New York
|
-$1.09M |
| 5 |
Walleye Capital
New York
|
-$540K |